
Venture capital
ARCH Venture Partners
ARCH Venture Partners is a science-driven venture firm based in Chicago and Seattle that founds and funds companies built on new technologies, with a portfolio concentrated in biotechnology and therapeutics.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is ARCH Venture Partners right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds ARCH Venture Partners joined, from press and the firm’s own posts.
9 rounds in the last 12 months
Round sizes, ARCH Venture Partners’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company ARCH Venture Partners backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet ARCH Venture Partners
Events where ARCH Venture Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
ARCH Venture Partners is based in Chicago, United States. It also has an office in Seattle.
13 fund vehicles are on public registers (SEC adviser filings), including ARCH VENTURE FUND XIII, LP, ARCH VENTURE FUND XII, LP and ARCH VENTURE FUND XI, LP.
ARCH follows the science to create companies around revolutionary technologies, taking a contrarian, long-term view. It sizes its investments to each company's needs, from very small initial checks to very large rounds. It also draws on a wide partner network to help companies through formation and growth. From the firm’s own website.
From $50K per investment, according to the firm’s own website.
ARCH Venture Partners lists 128 portfolio companies on its website, including 908 Devices, Accompany Health, Aera Therapeutics, Agios Pharmaceuticals and AIRNA.
Firms whose websites list some of the same companies include Foresite Capital, Pivotal Life Sciences and RA Capital.
Know before ARCH Venture Partners’s next round is announced.
PRO tracks ARCH Venture Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.